Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression

被引:15
|
作者
Gange, SJ
Mellors, JW
Lau, B
Detels, R
Phair, JP
Muñoz, A
Margolick, JB
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Univ Pittsburgh, Sch Med, Dept Hlth Med, Pittsburgh, PA USA
[3] Vet Affairs Med Ctr, Pittsburgh, PA USA
[4] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA
[5] Northwestern Univ, Sch Med, Dept Med, Div Infect Dis, Chicago, IL 60611 USA
[6] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
关键词
D O I
10.1089/088922201750461276
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Longitudinal measurements of plasma HIV RNA were analyzed using novel segmented regression models for 62 men in the Multicenter AIDS Cohort Study who at enrollment in 1985 were HIV seropositive and who had stable CD4(+) lymphocyte counts and no clinical disease progression for a 6-year period between 1985 and 1991. Through 1996, 20 of the men developed clinical AIDS or died (late progressors) and 42 remained asymptomatic (nonprogressors). Using segmented regression model methods, we estimated, for each individual, the time when a change in HIV RNA trajectory was most likely to have occurred. Prior to this time, late progressors and nonprogressors had stable plasma HIV RNA levels, although the mean level in late progressors was 0.42 log(10) copies/ml higher than in nonprogressors (p = 0.018). Furthermore, late progressors showed significant increases in HIV RNA levels of 0.23 log(10) copies/ml/year (1.7-fold increase/year). This increase in HIV RNA in the late progressors began approximately 1.1 years prior to the onset of their decline in CD4(+) lymphocytes, and 4.8 years prior to the onset of AIDS. These results provide evidence that an increase in the slope of plasma levels of HIV RNA is a sign of incipient progression of HIV disease.
引用
收藏
页码:1223 / 1229
页数:7
相关论文
共 50 条
  • [41] Type 1 and type 2 cytokines in HIV infection - A possible role in apoptosis and disease progression
    Clerici, M
    Fusi, ML
    Ruzzante, S
    Piconi, S
    Biasin, M
    Arienti, D
    Trabattoni, D
    Villa, ML
    ANNALS OF MEDICINE, 1997, 29 (03) : 185 - 188
  • [42] HIV-RNA and soluble immune activation markers to predict disease progression in HIV-1-infection.
    Zangerle, R
    Sarcletti, M
    Steinhuber, S
    Petter, A
    Fuchs, D
    Most, J
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 259 - 259
  • [43] Tracing the patterns of HIV-1 transmission among individuals with different time to diagnosis in Greece
    Kostaki, E-G
    Limnaios, S.
    Adamis, G.
    Xylomenos, G.
    Chini, M.
    Mangafas, N.
    Lazanas, M.
    Patrinos, S.
    Metallidis, G. S.
    Tsachouridou, O.
    Papastamopoulos, V.
    Chatzidimitriou, D.
    Kakalou, E.
    Kavatha, D.
    Papadopoulos, A.
    Protopapas, K.
    Psichogiou, M.
    Basoulis, D.
    Pilalas, D.
    Paraskeva, D.
    Chrysos, G.
    Paparizos, V.
    Kourkounti, S.
    Sambatakou, H.
    Sipsas, N. V.
    Lada, M.
    Barbounakis, E.
    Kantzilaki, E.
    Panagopoulos, P.
    Maltezos, E.
    Drimis, S.
    Magiorkinis, G.
    Skoura, L.
    Sypsa, V.
    Hatzakis, A.
    Paraskevis, D.
    HIV MEDICINE, 2019, 20 : 109 - 110
  • [44] MAPPING PATTERNS OF CAUSAL ATTRIBUTIONS FOR TYPE 1 AND TYPE 2 DIABETES AMONG AFFECTED AND UNAFFECTED INDIVIDUALS
    Rose, Margaret K.
    Costabile, Kristi A.
    Cohen, Rachel W.
    Persky, Susan
    ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 : S44 - S44
  • [45] Disease progression in HIV-1 or HIV-2-infected individuals of West African origin resident in the West
    Jaffar, S
    Hall, AJ
    AIDS, 1997, 11 (11) : 1398 - 1399
  • [46] Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study
    Wang, Linwei
    Krebs, Emanuel
    Min, Jeong E.
    Mathews, W. Christopher
    Nijhawan, Ank
    Somboonwit, Charurut
    Aberg, Judith A.
    Moore, Richard D.
    Gebo, Kelly A.
    Nosyk, Bohdan
    LANCET HIV, 2019, 6 (08): : E531 - E539
  • [47] Progression of HIV disease among women following delivery
    Watts, DH
    Lambert, J
    Stiehm, ER
    Harris, DR
    Bethel, J
    Mofenson, L
    Meyer, WA
    Mathieson, B
    Fowler, MG
    Nemo, G
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (05) : 585 - 593
  • [48] Disease progression in Niemann-Pick disease, type C: Longitudinal
    Yanjanin, Nicole
    Brewer, Carmen
    King, Kelly
    Pavan, William
    Gropman, Andrea
    Patterson, Marc
    Porter, Forbes
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S44 - S44
  • [49] HIV type 1 RNA expression in bone marrows of patients with a spectrum of disease
    Weiser, B
    Burger, H
    Campbell, P
    Donelan, S
    Mladenovic, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (16) : 1551 - 1558
  • [50] A Prediction Model of Chronic Kidney Disease Progression among Individuals with Type 2 Diabetes in the United States
    Lin, Yilu
    Shao, Hui
    Anderson, Amanda H.
    Fonseca, Vivian
    Batuman, Vecihi
    Shi, Lizheng
    DIABETES, 2022, 71